In lung cancer, hyperactivation of SETDB1 was found to influence various pathways, such as the WNT, MAPK, Toll-like receptors (TLRs), focal adhesion, and JAK-STAT pathways [11]. The gene discussed is SETDB1; the disease is lung carcinoma.